From Experiment to Accepted: How In-Silico is Redefining CMC with Regulatory Confidence

  • Share:

This webinar explores how in-silico modeling and digital tools are transforming Chemistry, Manufacturing, and Controls (CMC) development by enabling more predictive, data-driven decision making. The discussion highlights how modeling and simulation can improve process understanding, reduce development timelines, and strengthen regulatory submissions. Experts also share how these approaches are increasingly gaining regulatory acceptance, helping companies de-risk development, optimize manufacturing strategies, and bring therapies to patients more efficiently.

  • Share:

Contact Us

Let’s Get Started

Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.

1.877.787.0177

510.732.0177

Pharmatech Associates, Inc.
9110 Alcosta Blvd. STE H #601
San Ramon CA 94583